Location: Waterloo | Ontario
Industry Focus: Healthcare
Subsectors: Biotechnology
Ourotech saves pharma companies up to 40% on preclinical cancer drug screening costs by using proprietary tumor engineering biomaterials to determine the most effective drugs in an early stage pipeline.
CEO
